{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:53:57Z","timestamp":1784091237157,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.yebeh.2023.109409","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T01:11:52Z","timestamp":1693962712000},"page":"109409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center"],"prefix":"10.1016","volume":"147","author":[{"given":"G.","family":"Ferrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-6454","authenticated-orcid":false,"given":"E.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-4663","authenticated-orcid":false,"given":"A.","family":"Vignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Savini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zambrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"La Briola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Canevini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yebeh.2023.109409_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"issue":"21","key":"10.1016\/j.yebeh.2023.109409_b0010","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.yebeh.2023.109409_b0015","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109409_b0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/epi.17496","article-title":"Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: four-year results from the expanded access program","volume":"64","author":"Szaflarski","year":"2023","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109409_b0025","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/epi.17000","article-title":"Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: results of a long-term open-label extension trial","volume":"62","author":"Patel","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109409_b0030","unstructured":"\u201cEpidyolex. Summary of product characteristics\u201d https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/epidyolex-epar-product-information_en.pdf"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109409_b0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.12603","article-title":"More than seizures: improving the lives of people with refractory epilepsy","volume":"22","author":"Mula","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2023.109409_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.seizure.2019.12.006","article-title":"Cannabis-based products for pediatric epilepsy: an updated systematic review","volume":"75","author":"Elliott","year":"2020","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2023.109409_b0045","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/epi.13815","article-title":"Quality of life in childhood epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol","volume":"58","author":"Rosenberg","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109409_b0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/acn3.51537","article-title":"Observational study of medical marijuana as a treatment for treatment-resistant epilepsies","volume":"9","author":"Devinsky","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"10125","key":"10.1016\/j.yebeh.2023.109409_b0055","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109409_b0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109409_b0065","first-page":"511","article-title":"Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI)","volume":"34","author":"Curcio","year":"2013","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109409_b0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2869.1996.00251.x","article-title":"The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence","volume":"5","author":"Bruni","year":"1996","journal-title":"J Sleep Res"},{"key":"10.1016\/j.yebeh.2023.109409_b0075","series-title":"The use of psychological testing for treatment planning and outcomes assessment: Instruments for children and adolescents","first-page":"179","article-title":"The Achenbach System of Empirically Based Assessment (ASEBA) for Ages 15 to 18 Years","author":"Achenbach","year":"2004"},{"key":"10.1016\/j.yebeh.2023.109409_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1027\/1015-5759.20.2.124","article-title":"Behavioral and emotional problems among Italian children aged 4 to 18 years as reported by parents and teachers","volume":"20","author":"Frigerio","year":"2004","journal-title":"Eur J Psychol Assess"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109409_b0085","first-page":"783","article-title":"Psychometric properties of the quality of life inventory-disability (QI-Disability) measure","volume":"28","author":"Downs","year":"2019","journal-title":"Qual life Res an Int J Qual life Asp Treat care Rehabil"},{"key":"10.1016\/j.yebeh.2023.109409_b0090","series-title":"Parenting stress index","author":"Abidin","year":"1995"},{"key":"10.1016\/j.yebeh.2023.109409_b0095","series-title":"Parenting stress index short form: Adattamento italiano","author":"Guarino","year":"2008"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109409_b0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109409_b0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.0013-9580.2004.47003.x","article-title":"The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy","volume":"45","author":"Johnson","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109409_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.07.020","article-title":"Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study","volume":"87","author":"Szaflarski","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109409_b0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40272-019-00341-x","article-title":"Purified cannabidiol for treatment of refractory epilepsies in pediatric patients with developmental and epileptic encephalopathy","volume":"21","author":"Pietrafusa","year":"2019","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.yebeh.2023.109409_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107297","article-title":"Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy","volume":"112","author":"Nenert","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yebeh.2018.02.009","article-title":"Cannabidiol for treatment of refractory childhood epilepsies: experience from a single tertiary epilepsy center in Slovenia","volume":"81","author":"Neubauer","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"43","key":"10.1016\/j.yebeh.2023.109409_b0130","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","article-title":"Inhibitory effects of cannabidiol on voltage-dependent sodium currents","volume":"293","author":"Ghovanloo","year":"2018","journal-title":"J Biol Chem"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2023.109409_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yebeh.2019.07.008","article-title":"Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label expanded access program","volume":"98","author":"Gaston","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.yebeh.2013.09.006","article-title":"Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)","volume":"31","author":"Cramer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107014","article-title":"Sleep disturbances in Italian children and adolescents with epilepsy: a questionnaire study","volume":"106","author":"Zambrelli","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109409_b0150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11910-022-01219-1","article-title":"The interaction between sleep and epilepsy","volume":"22","author":"Roliz","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109409_b0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/epi.13617","article-title":"Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients","volume":"58","author":"Treat","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109409_b0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2015.02.043","article-title":"Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy","volume":"45","author":"Press","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108205","article-title":"Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy","volume":"122","author":"Strickland","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108325","article-title":"Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol","volume":"124","author":"Anderson","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2023.109409_b0175","article-title":"Outcomes from a Spanish expanded access program on cannabidiol treatment in pediatric and adult patients with epilepsy","volume":"137","author":"Villanueva","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109159","article-title":"Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex\u00ae (cannabidiol) in patients with refractory epilepsy","volume":"141","author":"Georgieva","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2019.03.035","article-title":"Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy","volume":"95","author":"Gaston","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109409_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.seizure.2021.05.014","article-title":"Two-center experience of cannabidiol use in adults with Dravet syndrome","volume":"91","author":"Silvennoinen","year":"2021","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109409_b0195","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00213-022-06196-4","article-title":"Cannabidiol for the treatment of autism spectrum disorder: hope or hype?","volume":"239","author":"Pedrazzi","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109409_b0200","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yebeh.2013.07.020","article-title":"Parenting stress evaluation and behavioral syndromes in a group of pediatric patients with epilepsy","volume":"29","author":"Farrace","year":"2013","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023003281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023003281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:52:01Z","timestamp":1761504721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023003281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":40,"alternative-id":["S1525505023003281"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109409","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109409"}}